Microglial polarization dynamics in dorsal spinal cord in the early stages following chronic sciatic nerve damage

Fangting Xu1, Juan Huang2, Zhenghua He1

  • 1Department of Anesthesiology, Xiangya Hospital of Central South University, Changsha 410008, China.

Neuroscience Letters
|January 29, 2016
PubMed

Insights

Peripheral nerve injury activates spinal microglia, initially both M1 and M2 phenotypes. After 7-14 days, microglia shift to a pro-inflammatory M1 phenotype, contributing to neuropathic pain.

Area of Science:

  • Neuroscience
  • Immunology
  • Pain Research

Background:

  • Peripheral nerve injury triggers spinal microglia activation, a key factor in neuroinflammation and neuropathic pain.
  • Microglia can adopt pro-inflammatory (M1) or anti-inflammatory (M2) phenotypes, influencing nervous system outcomes.
  • Understanding microglia dynamics post-injury is crucial for developing targeted pain therapies.

Purpose of the Study:

  • To investigate microglia activation, phenotype, and gene expression in the dorsal spinal cord following sciatic nerve chronic constriction injury (CCI) in rats.
  • To correlate microglial changes with the development of neuropathic pain over a 14-day period.

Main Methods:

  • Sciatic nerve chronic constriction injury (CCI) model in rats.
  • Analysis of microglia numbers and morphology in the dorsal spinal cord.
  • Examination of M1 and M2 microglia-related gene profiles at days 1, 7, and 14 post-injury.

Main Results:

  • Microglia morphology shifted to an activated state within 1 day of CCI.
  • Neuropathic pain emerged between 7 and 14 days post-CCI, accompanied by increased numbers of activated microglia.
  • Initially, both M1 and M2 microglia gene markers were upregulated at day 1.
  • By days 7 and 14, only M1 microglia gene markers remained significantly elevated, indicating a shift towards a pro-inflammatory phenotype.

Conclusions:

  • Both M1 and M2 microglia are activated early after peripheral nerve injury.
  • The sustained elevation of M1 markers suggests a shift towards a pro-inflammatory microglial response, potentially driving neuropathic pain development.
  • These findings highlight the evolving role of microglia in neuropathic pain pathogenesis.